Since the injected cell number of CD133− (100,000/mouse) was far greater than that of the CD133+ cells (1,500/mouse), this result indicated that the tumor-forming capacity of CD133− cells was lower than that of the CD133+ cells. The gene discussed is PROM1; the disease is neoplasm.